Paclitaxel: application in modern oncology and nanomedicine‐based cancer therapy

J Sharifi-Rad, C Quispe, JK Patra… - Oxidative medicine …, 2021 - Wiley Online Library
Paclitaxel is a broad‐spectrum anticancer compound, which was derived mainly from a
medicinal plant, in particular, from the bark of the yew tree Taxus brevifolia Nutt. It is a …

Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose–response meta-analysis of large prospective studies

L Garcia, M Pearce, A Abbas, A Mok, T Strain… - British Journal of …, 2023 - bjsm.bmj.com
Objective To estimate the dose–response associations between non-occupational physical
activity and several chronic disease and mortality outcomes in the general adult population …

Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies

YH Wang, JQ Li, JF Shi, JY Que, JJ Liu, JM Lappin… - Molecular …, 2020 - nature.com
The link between depression and anxiety status and cancer outcomes has been well-
documented but remains unclear. We comprehensively quantified the association between …

Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to …

Global Burden of Disease Cancer Collaboration - JAMA oncology, 2019 - research.ed.ac.uk
Objective: To describe cancer burden for 29 cancer groups in 195 countries from 1990
through 2017 to provide data needed for cancer control planning. Evidence Review: We …

[HTML][HTML] NAFLD‐related hepatocellular carcinoma: The growing challenge

PA Shah, R Patil, SA Harrison - Hepatology, 2023 - journals.lww.com
Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and
morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the …

Burden of liver diseases in the world

SK Asrani, H Devarbhavi, J Eaton, PS Kamath - Journal of hepatology, 2019 - Elsevier
Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due
to complications of cirrhosis and 1 million due to viral hepatitis and hepatocellular …

[HTML][HTML] METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST

X Yang, S Zhang, C He, P Xue, L Zhang, Z He, L Zang… - Molecular cancer, 2020 - Springer
Abstract Background N6-methyladenosine (m6A) is the most prevalent RNA epigenetic
regulation in eukaryotic cells. However, understanding of m6A in colorectal cancer (CRC) is …

Emerging trends in the novel drug delivery approaches for the treatment of lung cancer

P Sharma, M Mehta, DS Dhanjal, S Kaur… - Chemico-biological …, 2019 - Elsevier
Cancer is one of the major diseases that cause a high number of deaths globally. Of the
major types of cancers, lung cancer is known to be the most chronic form of cancer in the …

[HTML][HTML] Metformin and its benefits for various diseases

Z Lv, Y Guo - Frontiers in endocrinology, 2020 - frontiersin.org
Metformin is a widely used biguanide drug due to its safety and low cost. It has been used
for over 60 years to treat type 2 diabetes at the early stages because of its outstanding ability …

[HTML][HTML] Evolution of cancer pharmacological treatments at the turn of the third millennium

L Falzone, S Salomone, M Libra - Frontiers in pharmacology, 2018 - frontiersin.org
The medical history of cancer began millennia ago. Historical findings of patients with
cancer date back to ancient Egyptian and Greek civilizations, where this disease was …